Research

Kevin Manemann, chief executive, Providence Southern California, completes a two-part interview with Ora Gordon, MD, about exciting developments in the field of genetic research. Part two features:

  • How cancers grow at a different pace
  • How molecular vulnerabilities of a tumor can determine how we treat a specific cancer

Part one can be viewed by scrolling down to the November issue of Clinical Connections.

Previous Article
Technology with Richard Shapiro, MD
Technology with Richard Shapiro, MD

Aquablation: Dr. Shapiro, urologist, discusses this new advanced, minimally invasive procedure for benign p...

Next Article
COVID-19:  Then, Now and Forever?
COVID-19: Then, Now and Forever?

Charles Bailey, MD, infection disease specialist, provides an update on COVID-19.